Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      USFDA issues 4 observations for Torrent Pharmaceuticals Indrad plant

      USFDA issues 4 observations for Torrent Pharmaceuticals Indrad plant

      Ruby Khatun Khatun15 May 2017 12:52 PM IST
      New Delhi: Drug firm Torrent Pharmaceuticals said the US health regulator has issued four observations after inspection of its Indrad facility in...
      Dr Lal PathLabs posts Q4 net profit at Rs 31 cr

      Dr Lal PathLabs posts Q4 net profit at Rs 31 cr

      Ruby Khatun Khatun15 May 2017 12:51 PM IST
      New Delhi: Diagnostic chain Dr Lal PathLabs reported a consolidated net profit of Rs 30.99 crore for the March quarter.The company had posted a net...
      After Stents, NPPA shifts its focus to 19 other Medical Devices, Check out details

      After Stents, NPPA shifts its focus to 19 other Medical Devices, Check out details

      Ruby Khatun Khatun15 May 2017 11:19 AM IST
      New Delhi: After slashing the prices of cardiac stents in the country Drug price regulator NPPA has now moved on its focus towards monitoring the...
      Pfizers pneumonia vaccine now part of immunization programme

      Pfizer's pneumonia vaccine now part of immunization programme

      Ruby Khatun Khatun15 May 2017 11:09 AM IST
      Drug firm Pfizer said its pneumonia vaccine PCV 13 has been included in India's immunisation programme in select states.The company's 13-valent...
      Boston Scientific Announces Positive European Registry Results For WATCHMAN, Left Atrial Appendage Closure Device

      Boston Scientific Announces Positive European Registry Results For WATCHMAN, Left Atrial Appendage Closure Device

      Ruby Khatun Khatun15 May 2017 10:56 AM IST
      MARLBOROUGH: Boston Scientific announced positive safety and efficacy rates of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device from the...
      HC stops Natco Pharma from exporting generic of Bayers cancer drug

      HC stops Natco Pharma from exporting generic of Bayers cancer drug

      Ruby Khatun Khatun15 May 2017 10:52 AM IST
      New Delhi: The Delhi High Court put on hold an order of its single judge allowing Indian generic drug makers to make, sell and export patented...
      Patanjali eyes Rs 1 lakh-crore turnover in next 5 years

      Patanjali eyes Rs 1 lakh-crore turnover in next 5 years

      Ruby Khatun Khatun14 May 2017 10:59 AM IST
      Ahmedabad: Baba Ramdev-led home-grown FMCG major Patanjali Ayurved, which posted a turnover of Rs 10,561 crore in the last fiscal, is now looking at a...
      Boston Scientific Receives USFDA Approval For RESONATE Family of ICDs and CRTDs

      Boston Scientific Receives USFDA Approval For RESONATE Family of ICDs and CRTDs

      Ruby Khatun Khatun14 May 2017 10:55 AM IST
      MARLBOROUGH: Boston Scientific has received U.S. Food and Drug Administration (FDA) approval for the Resonate™ family of implantable cardioverter...
      3rd WHO Global Forum on Medical Devices will be New Delhi

      3rd WHO Global Forum on Medical Devices will be New Delhi

      Ruby Khatun Khatun14 May 2017 10:52 AM IST
      Geneva: New Delhi will be the venue for the next WHO Global Forum on Medical Devices, the most prestigious and biggest global congregation on medical...
      Quality main issue in prescribing generic drugs: CII president Shobana Kamineni

      Quality main issue in prescribing generic drugs: CII president Shobana Kamineni

      Ruby Khatun Khatun14 May 2017 10:44 AM IST
      New Delhi: Sounding a note of caution on the MCI move asking doctors to prescribe only generic medicines, CII President Shobana Kamineni has said poor...
      300,000 doses of Mercks Ebola shot available for emergencies: GAVI Vaccine Alliance

      300,000 doses of Merck's Ebola shot available for emergencies: GAVI Vaccine Alliance

      Ruby Khatun Khatun14 May 2017 9:52 AM IST
      The GAVI global vaccine alliance said on Friday some 300,000 emergency doses of an Ebola vaccine developed by Merck could be available in case of a...
      FDA Approves new device to treat esophageal birth defect in babies

      FDA Approves new device to treat esophageal birth defect in babies

      Ruby Khatun Khatun13 May 2017 12:51 PM IST
      The U.S. Food and Drug Administration (FDA) authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok